About us

Currently the government pays more attention to the development of high technologies in medicine.

Radiation diagnostics and therapy is a medical direction dynamically developing in the whole world. Its new technologies make it possible, for instance, to research and treat oncological diseases with application of isotopes with no radical surgery required.
In Russia such direction still falls behind world growth indicators, but there has been a tendency to reduce such gap demonstrated within recent years.

BEBIG Company was found in July, 2004, in order to bring high-tech and innovation oncological diseases treatment methods in Russian market. Such direction has become a priority for further development of the Company.

Since 2006, the Company management’s main task has been promotion of brachytherapy method in Russia as a high-tech prostate gland cancer treatment method. The method has proven its high efficiency at numerous health institutions of Russia. By now, already 17 health institutions apply brachytherapy as a treatment method throughout Russia.

Based on this, there is an issue of launching a domestic line of iodine-125-based microsources production used for brachytherapy, earlier bought abroad, arisen.

In March, 2008, at the Company management’s initiative an application for financing of a project on production of microsources containing iodine-125 was submitted to State Corporation Russian Corporation of Nanotechnologies (ROSNANO). Prior to application’s submission, hard work had been done during several years: performing of R&D works (research and development works), analyzing of market needs and potential. At the stage of research and development works, BEBIG Company was supported by the Fund of Support of small Businesses in the Sphere of Research and Technology. At the end of 2006-beginning of 2007, the Fund started financing of R&D works fulfillment under the following project: OOO BEBIG – “Development of Iodine-125 microsources for prostate gland cancer treatment”. R&D works duration – 3 years. Besides, experts of OOO BEBIG actively cooperated with leading radiologists and oncologists, who were very excited about our project.

Thanks to cooperation with the Fund, necessary facilities for microsources production in accordance with GMP (approximately 100 m2), were built, required equipment manufactured. There was a certain number of work places created, and for further production expansion 30 new employees will be hired.

The technology of microsources production obtained has a social important meaning, as we managed to obtain a product, the cost of which is lower than the same of its foreign equivalents, allowing application of this treatment technique by a wider range of medical institutions, and therefore, cure more men of prostate gland cancer.

Looking further ahead, we hope that our experience obtained during implementation of this project will be useful when implementing perspective technologies, which are currently in development.